Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Treasury Shares (2023 - 2025)

TriSalus Life Sciences (TLSI) has 3 years of Treasury Shares data on record, last reported at $1.8 million in Q4 2025.

  • For Q4 2025, Treasury Shares rose 297.65% year-over-year to $1.8 million; the TTM value through Dec 2025 reached $1.8 million, up 297.65%, while the annual FY2025 figure was $1.8 million, 297.65% up from the prior year.
  • Treasury Shares reached $1.8 million in Q4 2025 per TLSI's latest filing, up from $459357.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.8 million in Q4 2025 and bottomed at $64173.0 in Q4 2023.
  • Average Treasury Shares over 3 years is $783381.0, with a median of $459357.0 recorded in 2024.
  • Peak YoY movement for Treasury Shares: soared 615.81% in 2024, then skyrocketed 297.65% in 2025.
  • A 3-year view of Treasury Shares shows it stood at $64173.0 in 2023, then skyrocketed by 615.81% to $459357.0 in 2024, then surged by 297.65% to $1.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $1.8 million in Q4 2025, $459357.0 in Q4 2024, and $64173.0 in Q4 2023.